Consolidation Intensification Fails in High-Risk Metastatic Ewing Sarcoma

(MedPage Today) -- Adding high-dose treosulfan and melphalan as further consolidation therapy for high-risk metastatic Ewing sarcoma failed to improve survival outcomes, a randomized phase III study showed. In an intention-to-treat population...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news